跳至主要内容
临床试验/NL-OMON43619
NL-OMON43619已完成2 期

Medical Nutrition in prodromal Alzheimer's Disease, a double-blind controlled 24-month study, with four times a 12 month extension study. - LipiDiDiet

Vrije Universiteit Medisch Centrum0 个研究点目标入组 55 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
55

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational invasive

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients between 55 and 85 years old with episodic memory disorder AND one of the following:
  • - cerebrospinalfluid beta amyloid 1-42/1-40 < 1 and/or T-tau > 350 pg/ml and/or phospho-tau > 60 pg/ml OR
  • - MRI evidence for medial temporal lobe atrophy OR
  • - abnormal FDG PET compatible with AD type changes

排除标准

  • - dementia (according to DSM-IV criteria)
  • - use of omega-3 preparations or high dose vitamins
  • - historical use of cholinesterase inhibitors of NDMA antagonists
  • - concomitant serious disease
  • - major depressive disorder
  • - participation in any other clinical trial last 30 days

研究者

相似试验